A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors Meeting Abstract

  

Authors:	O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
Abstract Title:	A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
Meeting Title:	2025 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	16 Suppl.
Meeting Dates:	2025 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-06-01
Start Page:	TPS2685
Language:	English
ACCESSION:	WOS:001534364700001
DOI:	10.1200/JCO.2025.43.16_suppl.TPS2685
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/227872